Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes
- PMID: 16946670
- DOI: 10.1097/01.iae.0000244285.79004.e6
Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes
Abstract
Purpose: To study the clinical characteristics and treatment outcomes after laser and surgical treatment in a series of infants with zone I retinopathy of prematurity (ROP).
Methods: Preterm infants less than 1,500 g at birth diagnosed with zone I ROP were studied. Fifty-seven consecutive eyes in 29 infants with zone I ROP were treated with indirect diode laser. Within zone I, two anatomic subgroups (anterior and posterior) were defined. Additionally, 27 eyes (15 patients) with retinal detachment secondary to zone I ROP were surgically treated. Structural outcomes were evaluated 3 months after surgery.
Results: Atypical morphologic characteristics were observed. Thirty-one out of 48 eyes (64.6%) with anterior zone I ROP and none of the 9 eyes with posterior zone I ROP had a favorable outcome (P < 0.001) after photocoagulation. In the surgery group, 14 out of 19 (74%) eyes with stage 4 and 1 out of 8 (13%) eyes with stage 5 had favorable outcomes.
Conclusions: Atypical clinical features can be observed in zone I ROP. A posterior localization of the disease carries a worse prognosis after laser photocoagulation. Surgical intervention can effectively reattach the retina in a significant number of zone I ROP-related retinal detachments.
Similar articles
-
Scleral buckling for stage 4 retinopathy of prematurity.Ophthalmic Surg Lasers. 2000 Sep-Oct;31(5):374-9. Ophthalmic Surg Lasers. 2000. PMID: 11011705
-
[The results of diode treatment of active phase of retinopathy of prematurity].Klin Oczna. 2003;105(6):395-7. Klin Oczna. 2003. PMID: 15049263 Polish.
-
Anatomic success of lens-sparing vitrectomy with and without scleral buckle for stage 4 retinopathy of prematurity.Am J Ophthalmol. 2007 May;143(5):810-3. doi: 10.1016/j.ajo.2007.01.017. Epub 2007 Feb 28. Am J Ophthalmol. 2007. PMID: 17335766
-
Treatment of retinopathy of prematurity.Early Hum Dev. 2008 Feb;84(2):95-9. doi: 10.1016/j.earlhumdev.2007.11.007. Early Hum Dev. 2008. PMID: 18280405 Review.
-
[Treatment of retinal detachment of the course of retinopathy of prematurity].Klin Oczna. 2003;105(5):322-5. Klin Oczna. 2003. PMID: 14746190 Review. Polish.
Cited by
-
Progress and Challenges of Anti-VEGF Agents and Their Sustained-Release Strategies for Retinal Angiogenesis.Drug Des Devel Ther. 2022 Sep 22;16:3241-3262. doi: 10.2147/DDDT.S383101. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36172053 Free PMC article. Review.
-
Treatment outcomes of combination of anti-vascular endothelial growth factor injection and laser photocoagulation in Type 1 ROP and APROP.Int Ophthalmol. 2022 Jan;42(1):95-101. doi: 10.1007/s10792-021-02004-8. Epub 2021 Aug 20. Int Ophthalmol. 2022. PMID: 34415476
-
Regression Rates Following the Treatment of Aggressive Posterior Retinopathy of Prematurity with Bevacizumab Versus Laser: 8-Year Retrospective Analysis.Med Sci Monit. 2016 Apr 10;22:1192-209. doi: 10.12659/msm.897095. Med Sci Monit. 2016. PMID: 27062023 Free PMC article.
-
Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.Ophthalmology. 2015 May;122(5):1008-15. doi: 10.1016/j.ophtha.2014.12.017. Epub 2015 Feb 14. Ophthalmology. 2015. PMID: 25687024 Free PMC article.
-
Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment.Beyoglu Eye J. 2020 Jul 29;5(2):73-80. doi: 10.14744/bej.2020.46855. eCollection 2020. Beyoglu Eye J. 2020. PMID: 35098067 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical